19 related articles for article (PubMed ID: 16219138)
1. Elevated Jagged-1 and Notch-1 expression in high grade and metastatic prostate cancers.
Zhu H; Zhou X; Redfield S; Lewin J; Miele L
Am J Transl Res; 2013; 5(3):368-78. PubMed ID: 23634247
[TBL] [Abstract][Full Text] [Related]
2. p21WAF1/CIP1 expression is a marker of poor prognosis in oral squamous cell carcinoma.
Nemes JA; Nemes Z; Márton IJ
J Oral Pathol Med; 2005 May; 34(5):274-9. PubMed ID: 15817070
[TBL] [Abstract][Full Text] [Related]
3. [Expression and clinical significance of vascular endothelial growth factor C and D in nasopharyngeal carcinoma].
Zhao GG; Xiang XJ; He YJ
Ai Zheng; 2007 Jan; 26(1):90-5. PubMed ID: 17222375
[TBL] [Abstract][Full Text] [Related]
4. [Expression and clinical significance of VEGF and its receptors Flt-1 and KDR in nasopharyngeal carcinoma].
Sha D; He YJ
Ai Zheng; 2006 Feb; 25(2):229-34. PubMed ID: 16480593
[TBL] [Abstract][Full Text] [Related]
5. Significance of immunohistochemical expression of p27 and involucrin as the marker of cellular differentiation of squamous cell carcinoma of the esophagus.
Nozoe T; Oyama T; Takenoyama M; Hanagiri T; Sugio K; Yasumoto K
Oncology; 2006; 71(5-6):402-10. PubMed ID: 17878746
[TBL] [Abstract][Full Text] [Related]
6. Correlation of Notch1 expression and activation to cisplatin-sensitivity of head and neck squamous cell carcinoma.
Zhang ZP; Sun YL; Fu L; Gu F; Zhang L; Hao XS
Ai Zheng; 2009 Feb; 28(2):100-3. PubMed ID: 19550121
[TBL] [Abstract][Full Text] [Related]
7. [Expression and Significance of Notch1, P21WAF1 and involucrin in nasopharyngeal carcinoma].
Wang M; Li JT; Zeng YX; Hou JH; Lin QQ
Ai Zheng; 2005 Oct; 24(10):1230-4. PubMed ID: 16219138
[TBL] [Abstract][Full Text] [Related]
8. Histopathological classification of nasopharyngeal carcinoma.
Wei KR; Xu Y; Liu J; Zhang WJ; Liang ZH
Asian Pac J Cancer Prev; 2011; 12(5):1141-7. PubMed ID: 21875256
[TBL] [Abstract][Full Text] [Related]
9. Psoriasis, involucrin, and protein kinase C.
Iizuka H; Takahashi H
Int J Dermatol; 1993 May; 32(5):333-8. PubMed ID: 8505157
[No Abstract] [Full Text] [Related]
10.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
11.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
12.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]